Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582023 · ClinicalTrials.gov registry record
Role of Positive Affect in Adjustment to HIV
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 160
- Enrollment target
NCT00582023: Completed study, sponsored by University of California, San Francisco.
NCT00582023 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582023 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the role of emotion and mood in the context of HIV.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2004-09 |
| Est. Completion | 2012-06 |
What the finished NCT00582023 record still lists
NCT00582023 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00582023 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00582023 about?
NCT00582023 is a clinical study titled "Role of Positive Affect in Adjustment to HIV". The purpose of this study is to examine the role of emotion and mood in the context of HIV.
What is the current status of trial NCT00582023?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2004-09. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT00582023?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia